• Chief Healthcare ExecutiveChief Healthcare Executive
  • Formulary WatchFormulary Watch
  • Managed Healthcare Executive
  • Medical EconomicsMedical Economics
Managed Healthcare Executive
Managed Healthcare Executive
Resource Centers
View MoreHIVLiver DiseaseSleep DisordersBiosimilarsCovid-19AsthmaEye CareMultiple SclerosisPost-Acute CarePrescription Digital TherapeuticsRespiratory ConditionsSubstance Use DisorderType II Inflammation
Spotlight
A Collaboration That Will Help Payers Recognize the Potential Digital Health Can Bring to PatientsAMCP AnnualAsembia’s 2022 Specialty Pharmacy SummitAMCP NexusThe Improving Patient Access PodcastWet Age-Related Macular Degeneration: Understanding Disease Impact and Refining Treatment ApproachesParadigms in Insulin Use for Type 2 DiabetesPBMI National ConferenceRespiratory ConditionsShort on staff? Efficiency—not hiring—may be the best answerSupporting Better Cancer Care Through Comprehensive Genomic Profiling (CGP)
Business
View MoreBusiness StrategyChronic DiseaseConsumersDrug CostsDrug PipelineFormularyHealth ManagementHealth/Disease StrategyHospitals & ProvidersIndustry AnalysisPharmacyPolitics and PolicyPractice ManagementReimbursementTechnology
News
Media
Expert Interviews
K-Cast
Medical World News
Podcasts
Population Health Perspectives
Conferences
Publications
MHE Publication
Supplements And Featured Publications
Events
Virtual Events
CME/CE
Resources
PBM Leaders
Sponsored
Sponsored Content
Surveys
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations

© 2022 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.

Resource CentersSee All >
  • HIV
  • Liver Disease
  • Sleep Disorders
  • Biosimilars
  • Covid-19
  • Asthma
  • Eye Care
  • Multiple Sclerosis
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Respiratory Conditions
  • Substance Use Disorder
  • Type II Inflammation
Spotlight
  • A Collaboration That Will Help Payers Recognize the Potential Digital Health Can Bring to Patients
  • AMCP Annual
  • Asembia’s 2022 Specialty Pharmacy Summit
  • AMCP Nexus
  • The Improving Patient Access Podcast
  • Wet Age-Related Macular Degeneration: Understanding Disease Impact and Refining Treatment Approaches
  • Paradigms in Insulin Use for Type 2 Diabetes
  • PBMI National Conference
  • Respiratory Conditions
  • Short on staff? Efficiency—not hiring—may be the best answer
  • Supporting Better Cancer Care Through Comprehensive Genomic Profiling (CGP)
BusinessSee All >
  • Business Strategy
  • Chronic Disease
  • Consumers
  • Drug Costs
  • Drug Pipeline
  • Formulary
  • Health Management
  • Health/Disease Strategy
  • Hospitals & Providers
  • Industry Analysis
  • Pharmacy
  • Politics and Policy
  • Practice Management
  • Reimbursement
  • Technology
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.

Management of Dry Eye Disease

Dr Laura Periman, MD discusses biopsychosocial and economic impacts, as well as innovative treatment opportunities for patients with dry eye disease.

EP. 1: Pathology and Prevalence of Dry Eye Disease

June 7th 2022

Dr Laura Periman, MD illustrates the current risk factors and prevalence regarding patients with dry eye disease.

EP. 2: Impact of Dry Eye Disease on Quality of Life

June 14th 2022

Quality-of-life concerns, including biopsychosocial impacts caused by dry eye disease, are explored by Dr Periman.

EP. 3: Identifying Drivers of Economic Burden Associated With Dry Eye Disease

June 21st 2022

Dr Periman addresses cost-related concerns associated with treating dry eye disease.

EP. 4: Exploring Non-Pharmacologic Treatment Options for Patients With Dry Eye Disease

June 28th 2022

Various treatments for dry eye disease are navigated with regard to both payer and provider considerations.